BioSpace News Archive

Forbion Continues Funding Efforts, Raises $208M for More Investments

Forbion, a European life sciences venture capital firm, announced today that it had closed its Forbion Growth Opportunities Fund at $208 million.

July 9, 2020
·
3 min read
·
Krystle Vermes
FDA

Therapixel receives FDA 510(k) clearance for MammoScreen™

MammoScreen ™ , the explainable and actionable artificial intelligence (AI) based software assisting Radiologists in reading screening mammograms, received 510(k) clearance K192854 from the U.S. Food and Drug Admin

July 9, 2020
·
2 min read
Job Trends

Second Systematic Review and Meta-Analysis Published Demonstrating DecisionDx-Melanoma as Independent Predictor of Recurrence, Distant Metastasis and Overall Survival in Cutaneous Melanoma

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced the publication of an independent, systematic review and meta-analysis demonstrating that its DecisionDx®-Melanoma test is a significant predictor of recurrence and metastatic risk in patients with invasive cutaneous melanoma.

July 9, 2020
·
6 min read
BioMidwest

Vagus Nerve Stimulation (VNS) Clinical Trial Begins Enrolling COVID-19 Patients

COVID-19 patients have begun enrolling in an interventional clinical trial at Hospital Virgen del Carmen in Zarate, Argentina.

July 9, 2020
·
2 min read
Pharm Country

CSL Behring Announces Professor Heimburger Awards in Advance of ISTH 2020 Virtual Congress

- Five coagulation researchers named this year’s recipients - Professor Heimburger Awards and ISTH Virtual Congress sponsorship showcase CSL Behring’s commitment to hematology research

July 9, 2020
·
5 min read
Drug Development

Kronos Bio Reports Positive Results of Preclinical Study of KB-0742, an Investigational CDK9 Inhibitor, Demonstrating Potency, Selectivity and Anti-tumor Activity in Prostate Cancer Model

Kronos Bio, Inc., dedicated to targeting oncogenic transcription factors and their associated transcriptional regulatory networks, today announced results of a preclinical study of KB-0742, a highly potent, orally available and selective cyc

July 9, 2020
·
2 min read
Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for TEPEZZA® (teprotumumab-trbw) Effective Oct. 1, 2020

Centers for Medicare & Medicaid Services (CMS) Issues Permanent J-Code for TEPEZZA ® (teprotumumab-trbw) Effective Oct. 1, 2020

July 9, 2020
·
6 min read
EGF Theramed Health Announces MOU with Greenfield Global Projects and Joint Venture Partner Green Parrot

EGF THERAMED HEALTH CORP. (CSE:TMED)(OTC PINK:EVAHF)(FRANKFURT:AUHP) (the “Company”) announces that Global Green Parrot Laboratories Inc. (“GGP”) has entered into a Memorandum of Understanding (“MOU”) with Greenfield Global Projects Inc. (“Greenfield”)

July 9, 2020
·
7 min read
Business

Innovega Welcomes Intellectual Property and Augmented Reality Expert to Board of Advisors

Innovega Inc. announced the appointment of Casey Tegreene as a Strategic and Technical Advisor to the company. Casey has decades of experience inventing, developing, protecting and commercializing a wide range of advanced technologies.

July 9, 2020
·
2 min read
BioMidwest

Medela Awarded 2020 Vendor of the Year by the Pacific Coast Region of the Wound, Ostomy, and Continence Nurses Society™ (WOCN®)

Medela’s Healthcare business receives prestigious recognition for its ongoing efforts to support WOC Nurses across the country

July 9, 2020
·
2 min read